Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506

被引:174
作者
Andoh, TF [1 ]
Burdmann, EA [1 ]
Fransechini, N [1 ]
Houghton, DC [1 ]
Bennett, WM [1 ]
机构
[1] OREGON HLTH SCI UNIV, DEPT PATHOL, PORTLAND, OR 97201 USA
关键词
D O I
10.1038/ki.1996.417
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Acute cyclosporine (CsA) nephrotoxicity is characterized by a reduction of glomerular filtration rate (GFR), hypomagnesemia and tubular injury. The mechanisms of CsA's immunosuppressive action and presumably its nephrotoxicity are mediated through inhibition of the renal phosphatase, calcineurin. FK506 (FK), which has a different chemical structure and binding immunuophilin, also inhibits calcineurin, We compared the renal effects of these drugs to those of rapamycin (RAPA), which although similar in structure and intracellular binding to FK, does not work by changing calcineurin activity. Rats were given CsA (15 mg/kg/s.c.), FK (6 mg/kg/p.o.). RAPA (3 mg/kg/p.o.) or vehicle (V) for two weeks on a low salt diet. CsA and FK strikingly decreased urinary excretion of nitric oxide, renal blood How and GFR, whereas RAPA did not. In contrast, all these three drugs caused significant hypomagnesemia associated with inappropriately high fractional excretion of magnesium, suggesting renal magnesium wasting. In addition, with all three drugs there were lesions in the rat kidneys consisting of tubular collapse, vacuolization and nephrocalcinosis. We thus showed that only the calcineurin inhibitors produced glomerular dysfunction in an acute experimental model of nephrotoxicity. The mechanism of hypomagnesemia and tubular injury induced by all three immunosuppressive drags is unclear but may be independent of calcineurin. The mechanism of renal vasoconstriction on the other hand mag. be related to inhibition of calcineurin.
引用
收藏
页码:1110 / 1117
页数:8
相关论文
共 42 条
  • [1] MAGNESIUM-DEFICIENCY - PATHOPHYSIOLOGIC AND CLINICAL OVERVIEW
    ALGHAMDI, SMG
    CAMERON, EC
    SUTTON, RAL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) : 737 - 752
  • [2] REDUCED ERYTHROCYTE AND LEUKOCYTE MAGNESIUM IS ASSOCIATED WITH CYCLOSPORINE TREATMENT AND HYPERTENSION IN RENAL-TRANSPLANT PATIENTS
    ALKHURSANY, I
    THOMAS, TH
    HARRISON, K
    WILKINSON, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (03) : 251 - 255
  • [3] ANDOH TF, 1994, TRANSPLANTATION, V57, P483
  • [4] FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF EXPERIMENTAL FK-506 NEPHROTOXICITY
    ANDOH, TF
    BURDMANN, EA
    LINDSLEY, J
    HOUGHTON, DC
    WILLIAM, M
    BENNETT, WM
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (09) : 646 - 654
  • [5] BENNETT WM, 1994, NEPHROL DIAL TRANSPL, V9, P141
  • [6] PREVENTION OF EXPERIMENTAL CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS BY LOSARTAN AND ENALAPRIL
    BURDMANN, EA
    ANDOH, TF
    NAST, CC
    EVAN, A
    CONNORS, BA
    COFFMAN, TM
    LINDSLEY, J
    BENNETT, WM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 269 (04) : F491 - F499
  • [7] IDENTIFICATION OF INCREASED NITRIC-OXIDE BIOSYNTHESIS DURING PREGNANCY IN RATS
    CONRAD, KP
    JOFFE, GM
    KRUSZYNA, H
    KRUSZYNA, R
    ROCHELLE, LG
    SMITH, RP
    CHAVEZ, JE
    MOSHER, MD
    [J]. FASEB JOURNAL, 1993, 7 (06) : 566 - 571
  • [8] ACUTE CYCLOSPORINE RENAL DYSFUNCTION REVERSED BY DOPAMINE INFUSION IN HEALTHY-SUBJECTS
    CONTE, G
    DALCANTON, A
    SABBATINI, M
    NAPODANO, P
    DENICOLA, L
    GIGLIOTTI, G
    FUIANO, G
    TESTA, A
    ESPOSITO, C
    RUSSO, D
    ANDREUCCI, VE
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (06) : 1086 - 1092
  • [9] IMMUNOSUPPRESSANT FK506 ENHANCES PHOSPHORYLATION OF NITRIC-OXIDE SYNTHASE AND PROTECTS AGAINST GLUTAMATE NEUROTOXICITY
    DAWSON, TM
    STEINER, JP
    DAWSON, VL
    DINERMAN, JL
    UHL, GR
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) : 9808 - 9812
  • [10] ARGININE FEEDING MODIFIES CYCLOSPORINE NEPHROTOXICITY IN RATS
    DENICOLA, L
    THOMSON, SC
    WEAD, LM
    BROWN, MR
    GABBAI, FB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1859 - 1865